SLC2A1 and neoplasm: Also, GLUT1 expression was associated with shorter overall and disease-free survival, indicating this protein can contribute to predict malignancy in pediatric ACTs, as, presently, there is no adequate scoring system to predict clinical behavior in this type of tumor [6, 9–11].